-
公开(公告)号:US07855292B2
公开(公告)日:2010-12-21
申请号:US11943520
申请日:2007-11-20
申请人: Brett Allison , Victor K. Phuong , Marna C. W. Pippel , Michael H. Rabinowitz , Hariharan Venkatesan
发明人: Brett Allison , Victor K. Phuong , Marna C. W. Pippel , Michael H. Rabinowitz , Hariharan Venkatesan
IPC分类号: C07D241/36
CPC分类号: C07D263/56 , C07C311/21 , C07D241/42 , C07D277/62 , C07D285/14 , C07D317/62 , C07D409/12 , C07D417/12
摘要: Certain sulfonamide compounds are dual CCK1/CCK2 inhibitors useful in the treatment of CCK1/CCK2 mediated diseases.
摘要翻译: 某些磺酰胺化合物是可用于治疗CCK1 / CCK2介导的疾病的双CCK1 / CCK2抑制剂。
-
公开(公告)号:US07297816B2
公开(公告)日:2007-11-20
申请号:US11230249
申请日:2005-09-19
申请人: Brett Allison , Victor K. Phuong , Marna C. W. Pippel , Michael H. Rabinowitz , Hariharan Venkatesan
发明人: Brett Allison , Victor K. Phuong , Marna C. W. Pippel , Michael H. Rabinowitz , Hariharan Venkatesan
IPC分类号: C07C303/00 , C07C307/00 , C07C309/00 , C07C311/00
CPC分类号: C07D263/56 , C07C311/21 , C07D241/42 , C07D277/62 , C07D285/14 , C07D317/62 , C07D409/12 , C07D417/12
摘要: Certain sulfonamide compounds are dual CCK1/CCK2 inhibitors useful in the treatment of CCK1/CCK2 mediated diseases.
摘要翻译: 某些磺酰胺化合物是可用于治疗CCK1 / CCK2介导的疾病的双CCK1 / CCK2抑制剂。
-
3.4-aminoquinazolin-2-yl-1-pyrrazole-4-carboxylic acid compounds as prolyl hydroxylase inhibitors 有权
标题翻译: 4-氨基喹唑啉-2-基-1-吡唑-4-羧酸化合物作为脯氨酰羟化酶抑制剂公开(公告)号:US08796263B2
公开(公告)日:2014-08-05
申请号:US13816747
申请日:2011-08-12
IPC分类号: A61K31/55 , A61K31/517 , A61K31/54 , C07D401/00 , C07D413/00 , C07D243/08 , C07D403/00
CPC分类号: C07D405/14 , A61K31/517 , C07D401/14 , C07D403/04 , C07D403/14 , C07D413/14 , C07D417/14
摘要: Aminoquinazolinyl compounds of formula (I) are described, which are useful as prolyl hydroxylase inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by prolyl hydroxylase activity. Thus, the compounds may be administered to treat, e.g., anemia, vascular disorders, metabolic disorders, and wound healing.
摘要翻译: 描述了式(I)的氨基喹唑啉基化合物,其可用作脯氨酰羟化酶抑制剂。 这些化合物可用于治疗由脯氨酰羟化酶活性介导的疾病状态,病症和病症的药物组合物和方法。 因此,可以施用化合物以治疗例如贫血,血管疾病,代谢紊乱和伤口愈合。
-
4.4-AMINOQUINAZOLIN-2-YL-1-PYRRAZOLE-4-CARBOXYLIC ACID COMPOUNDS AS PROLYL HYDROXYLASE INHIBITORS 有权
标题翻译: 4-氨基喹唑啉-2-基-L- 1-吡唑-4-羧酸化合物作为丙二醇羟化酶抑制剂公开(公告)号:US20130143871A1
公开(公告)日:2013-06-06
申请号:US13816747
申请日:2011-08-12
IPC分类号: C07D403/04 , A61K31/55 , C07D405/14 , C07D401/14 , C07D417/14 , C07D403/14 , A61K31/517 , A61K31/551 , A61K31/5377 , C07D413/14
CPC分类号: C07D405/14 , A61K31/517 , C07D401/14 , C07D403/04 , C07D403/14 , C07D413/14 , C07D417/14
摘要: Aminoquinazolinyl compounds of formula (I) are described, which are useful as prolyl hydroxylase inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by prolyl hydroxylase activity. Thus, the compounds may be administered to treat, e.g., anemia, vascular disorders, metabolic disorders, and wound healing.
摘要翻译: 描述了式(I)的氨基喹唑啉基化合物,其可用作脯氨酰羟化酶抑制剂。 这些化合物可用于治疗由脯氨酰羟化酶活性介导的疾病状态,病症和病症的药物组合物和方法。 因此,可以施用化合物以治疗例如贫血,血管疾病,代谢紊乱和伤口愈合。
-
公开(公告)号:US20110046132A1
公开(公告)日:2011-02-24
申请号:US12990104
申请日:2009-04-28
申请人: Frances Meredith Hocutt , Barry Eastman Leonard, JR. , Hillary M. Peltier , Victor K. Phuong , Michael H. Rabinowitz , Mark D. Rosen , Kyle T. Tarantino , Hariharan Venkatesan , Lucy Xiumin Zhao
发明人: Frances Meredith Hocutt , Barry Eastman Leonard, JR. , Hillary M. Peltier , Victor K. Phuong , Michael H. Rabinowitz , Mark D. Rosen , Kyle T. Tarantino , Hariharan Venkatesan , Lucy Xiumin Zhao
IPC分类号: A61K31/5377 , C07D403/04 , C07D403/14 , C07D401/14 , C07D413/14 , C07D471/04 , C07D513/04 , C07D487/14 , C07D487/04 , C07D473/40 , A61K31/4184 , A61K31/454 , A61K31/437 , A61K31/429 , A61K31/496 , A61K31/4985 , A61K31/52 , A61P7/06 , A61P9/10 , A61P9/00 , A61P3/10 , A61P3/04 , A61P29/00 , A61P17/02 , A61P19/08
CPC分类号: C07D403/04 , C07D235/24 , C07D403/14 , C07D471/04 , C07D473/40 , C07D487/04 , C07D513/04
摘要: The present invention is directed to benzoimidazole compounds of the formula (1) and enantiomers, diastereomers, racemates, and pharmaceutically acceptable salts thereof. Compounds of the present invention are useful in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions modulated by prolyl hydroxylase activity.
摘要翻译: 本发明涉及式(1)的苯并咪唑化合物及其对映体,非对映异构体,外消旋体及其药学上可接受的盐。 本发明的化合物可用于治疗由脯氨酰羟化酶活性调节的疾病状态,病症和状况的药物组合物和方法。
-
公开(公告)号:US07304051B2
公开(公告)日:2007-12-04
申请号:US10910925
申请日:2004-08-04
CPC分类号: C04B35/632 , C07D241/42 , C07D401/12 , C07D403/12 , C07D413/12
摘要: Amidophenyl-sulfonylamino-quinoxaline compounds of formula (I) are CCK2 modulators useful in the treatment of CCK2 mediated diseases.
摘要翻译: 式(I)的苯基磺酰氨基 - 喹喔啉化合物
-
公开(公告)号:US08759345B2
公开(公告)日:2014-06-24
申请号:US12990104
申请日:2009-04-28
申请人: Frances Meredith Hocutt , Barry Eastman Leonard, Jr. , Hillary M Peltier , Victor K. Phuong , Michael H. Rabinowitz , Mark D Rosen , Kyle T. Tarantino , Hariharan Venkatesan , Lucy Xiumin Zhao
发明人: Frances Meredith Hocutt , Barry Eastman Leonard, Jr. , Hillary M Peltier , Victor K. Phuong , Michael H. Rabinowitz , Mark D Rosen , Kyle T. Tarantino , Hariharan Venkatesan , Lucy Xiumin Zhao
IPC分类号: C07D403/04 , C07D403/14 , C07D487/04 , C07D401/14 , C07D413/14 , C07D471/04 , C07D513/04 , C07D487/14 , A61K31/5377 , A61K31/454 , A61K31/437 , A61K31/429 , A61K31/496 , A61K31/4985 , A61K31/52 , A61P7/06
CPC分类号: C07D403/04 , C07D235/24 , C07D403/14 , C07D471/04 , C07D473/40 , C07D487/04 , C07D513/04
摘要: The present invention is directed to benzoimidazole compounds of the formula (1) and enantiomers, diastereomers, racemates, and pharmaceutically acceptable salts thereof. Compounds of the present invention are useful in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions modulated by prolyl hydroxylase activity.
摘要翻译: 本发明涉及式(1)的苯并咪唑化合物及其对映体,非对映异构体,外消旋体及其药学上可接受的盐。 本发明的化合物可用于治疗由脯氨酰羟化酶活性调节的疾病状态,病症和状况的药物组合物和方法。
-
公开(公告)号:US20100292240A1
公开(公告)日:2010-11-18
申请号:US12843682
申请日:2010-07-26
申请人: Brett Allison , Victor K. Phuong , Mama C.W. Pippel , Michael H. Rabinowitz , Hariharan Venkatesan
发明人: Brett Allison , Victor K. Phuong , Mama C.W. Pippel , Michael H. Rabinowitz , Hariharan Venkatesan
IPC分类号: A61K31/498 , C07D285/14 , C07D417/12 , C07D241/42 , C07C311/21 , C07D263/56 , C07D317/62 , A61K31/433 , A61K31/18 , A61K31/423 , A61K31/36 , A61P25/30 , A61P1/04 , A61P35/00 , A61P3/04 , A61P1/18 , A61P25/22
CPC分类号: C07D263/56 , C07C311/21 , C07D241/42 , C07D277/62 , C07D285/14 , C07D317/62 , C07D409/12 , C07D417/12
摘要: Certain sulfonamide compounds are dual CCK1/CCK2 inhibitors useful in the treatment of CCK1/CCK2 mediated diseases.
摘要翻译: 某些磺酰胺化合物是可用于治疗CCK1 / CCK2介导的疾病的双CCK1 / CCK2抑制剂。
-
公开(公告)号:US07241759B2
公开(公告)日:2007-07-10
申请号:US10811292
申请日:2004-03-26
IPC分类号: A61K31/433 , A61K31/445 , A61K31/496 , C07D265/30 , C07D285/14
CPC分类号: C07D285/14 , C07D285/10 , C07D417/12
摘要: Certain amidophenyl-sulfanylamino-benzo[1,2,5]thiadiazole compounds are CCK2 modulators useful in the treatment of CCK2 mediated diseases.
摘要翻译: 某些氨基 - 苯硫基氨基 - 苯并[1,2,5]噻二唑化合物是可用于治疗CCK2介导的疾病的CCK2调节剂。
-
公开(公告)号:US07563895B2
公开(公告)日:2009-07-21
申请号:US11950326
申请日:2007-12-04
IPC分类号: C07D241/4237
CPC分类号: C04B35/632 , C07D241/42 , C07D401/12 , C07D403/12 , C07D413/12
摘要: Certain amidophenyl-sulfonylamino-quinoxaline compounds are CCK2 modulators useful in the treatment of CCK2 mediated diseases.
摘要翻译: 苯基磺酰氨基 - 喹喔啉化合物中的某些化合物是可用于治疗CCK2介导的疾病的CCK2调节剂。
-
-
-
-
-
-
-
-
-